Petmed Express Company Profile (NASDAQ:PETS)

About Petmed Express (NASDAQ:PETS)

Petmed Express logoPetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Delivery
  • Sub-Industry: Internet Retail
  • Symbol: NASDAQ:PETS
  • CUSIP: 71638210
  • Web:
  • Market Cap: $694.31 million
  • Outstanding Shares: 20,260,000
Average Prices:
  • 50 Day Moving Avg: $25.94
  • 200 Day Moving Avg: $22.67
  • 52 Week Range: $17.70 - $35.88
  • Trailing P/E Ratio: 29.29
  • Foreward P/E Ratio: 25.01
  • P/E Growth: 2.73
Sales & Book Value:
  • Annual Revenue: $249.18 million
  • Price / Sales: 2.79
  • Book Value: $4.61 per share
  • Price / Book: 7.43
  • Annual Dividend: $0.76
  • Dividend Yield: 2.2%
  • EBIDTA: $38.85 million
  • Net Margins: 9.00%
  • Return on Equity: 25.06%
  • Return on Assets: 22.63%
  • Current Ratio: 8.53%
  • Quick Ratio: 6.65%
  • Average Volume: 394,168 shs.
  • Beta: 1.02
  • Short Ratio: 17.73

Frequently Asked Questions for Petmed Express (NASDAQ:PETS)

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, May 8th. Investors of record on Friday, May 19th will be given a dividend of $0.20 per share on Friday, May 26th. This represents a $0.80 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date is Wednesday, May 17th. This is a boost from Petmed Express's previous quarterly dividend of $0.19. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings data on Monday, May, 8th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.11. The business had revenue of $63.03 million for the quarter, compared to analysts' expectations of $56.53 million. Petmed Express had a net margin of 9.00% and a return on equity of 25.06%. Petmed Express's revenue for the quarter was up 13.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.27 earnings per share. View Petmed Express' Earnings History.

Where is Petmed Express' stock going? Where will Petmed Express' stock price be in 2017?

2 brokers have issued 12 month price objectives for Petmed Express' stock. Their predictions range from $13.00 to $13.00. On average, they expect Petmed Express' stock price to reach $13.00 in the next year. View Analyst Ratings for Petmed Express.

Who are some of Petmed Express' key competitors?

Who owns Petmed Express stock?

Petmed Express' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (8.82%), Vanguard Group Inc. (5.31%), Dimensional Fund Advisors LP (3.92%), Uniplan Investment Counsel Inc. (2.18%), Morgan Stanley (2.14%) and Bank of New York Mellon Corp (1.89%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Who sold Petmed Express stock? Who is selling Petmed Express stock?

Petmed Express' stock was sold by a variety of institutional investors in the last quarter, including Hancock Holding Co., LSV Asset Management, JPMorgan Chase & Co., AQR Capital Management LLC, Morgan Stanley, Advisors Asset Management Inc., UBS Group AG and U S Global Investors Inc. Company insiders that have sold Petmed Express stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Who bought Petmed Express stock? Who is buying Petmed Express stock?

Petmed Express' stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, Citadel Advisors LLC, Oxford Asset Management, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Vanguard Group Inc. and TD Asset Management Inc.. View Insider Buying and Selling for Petmed Express.

How do I buy Petmed Express stock?

Shares of Petmed Express can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Petmed Express stock cost?

One share of Petmed Express stock can currently be purchased for approximately $34.27.

Analyst Ratings

Consensus Ratings for Petmed Express (NASDAQ:PETS) (?)
Ratings Breakdown: 1 Sell Rating, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $13.00 (62.07% downside)

Analysts' Ratings History for Petmed Express (NASDAQ:PETS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/4/2017Craig HallumUpgradeHold -> BuyLowView Rating Details
8/16/2016Credit Suisse Group AGReiterated RatingSell$13.00N/AView Rating Details
(Data available from 5/24/2015 forward)


Earnings History for Petmed Express (NASDAQ:PETS)
Earnings by Quarter for Petmed Express (NASDAQ:PETS)
Earnings History by Quarter for Petmed Express (NASDAQ:PETS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Petmed Express (NASDAQ:PETS)
2017 EPS Consensus Estimate: $1.06
2018 EPS Consensus Estimate: $1.30
2019 EPS Consensus Estimate: $1.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.30$0.30$0.30
Q2 20172$0.23$0.28$0.26
Q3 20172$0.23$0.26$0.25
Q4 20172$0.25$0.26$0.26
Q1 20182$0.38$0.40$0.39
Q2 20182$0.25$0.27$0.26
Q3 20181$0.26$0.26$0.26
Q4 20182$0.38$0.40$0.39
Q1 20192$0.42$0.45$0.44
Q2 20192$0.27$0.30$0.29
Q3 20191$0.29$0.29$0.29
Q4 20192$0.40$0.45$0.43
(Data provided by Zacks Investment Research)


Current Dividend Information for Petmed Express (NASDAQ:PETS)
Next Dividend:5/26/2017
Annual Dividend:$0.76
Dividend Yield:2.22%
Payout Ratio:71.03% (Trailing 12 Months of Earnings)
59.38% (Based on This Year's Estimates)
55.47% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Petmed Express (NASDAQ:PETS)

Dividend History by Quarter for Petmed Express (NASDAQ:PETS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Petmed Express (NASDAQ:PETS)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 73.16%
Insider Trades by Quarter for Petmed Express (NASDAQ:PETS)
Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)
Insider Trades by Quarter for Petmed Express (NASDAQ:PETS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.00View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.00View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.00View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.00View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.00View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.00View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.00View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.00View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.00View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.00View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.00View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.00View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.00View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.00View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.00View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.00View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.00View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.00View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.00View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.00View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Petmed Express (NASDAQ:PETS)
Latest Headlines for Petmed Express (NASDAQ:PETS)
DateHeadline logo$77.39 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter - May 21 at 2:46 PM logoPetMed Express, Inc. : PETS-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers : May 19, 2017 - May 19 at 7:46 PM logoInsider Selling: Petmed Express Inc (PETS) Director Sells 5,000 Shares of Stock - May 16 at 7:53 PM logo Brokerages Anticipate Petmed Express Inc (PETS) to Post $0.39 EPS - May 16 at 8:24 AM logoEdited Transcript of PETS earnings conference call or presentation 8-May-17 12:30pm GMT - May 12 at 7:54 PM logo Petmed Express Inc (PETS) Receives Average Recommendation of "Buy" from Brokerages - May 12 at 10:56 AM logoCan The Uptrend Continue for Petmed Express (PETS)? - May 12 at 8:20 AM logoGian Fulgoni Sells 35,000 Shares of Petmed Express Inc (PETS) Stock - May 11 at 4:28 PM logoCraig Hallum Analysts Increase Earnings Estimates for Petmed Express Inc (PETS) - May 11 at 2:58 PM logoInvestors Loving This Stock Like People Love Their Pets - May 10 at 7:23 PM logoPetmed Express Inc (PETS) to Post Q2 2018 Earnings of $0.27 Per Share, Northcoast Research Forecasts - May 10 at 1:50 PM logoBrokers Set Expectations for Petmed Express Inc's Q1 2018 Earnings (PETS) - May 10 at 1:08 PM logoPetmed Express Inc (PETS) Lifted to "Strong-Buy" at Zacks Investment Research - May 10 at 1:00 PM logoPetMed Express, Inc.: Leads amongst peers with strong fundamentals - May 9 at 6:44 PM logoPetmed Express Inc (PETS) Insider Sells $243,000.00 in Stock - May 9 at 4:36 PM logoBloomberg Markets: Dave Wilson’s Stock of the Day for May 8 - May 9 at 11:11 AM logoQ1 2018 Earnings Forecast for Petmed Express Inc Issued By Northcoast Research (PETS) - May 9 at 10:46 AM logoPetmed Express Inc (PETS) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - May 8 at 8:38 PM logoWhy Petmed Express Inc's Shares Popped 26% Today - May 8 at 6:34 PM logoWhy Petmed Express Inc's Shares Popped 26% Today - May 8 at 4:34 PM logoPetmed Express Inc (PETS) to Issue Quarterly Dividend of $0.20 - May 8 at 12:32 PM logoInvestor Network: PETMED EXPRESS INC. to Host Earnings Call - May 8 at 12:04 PM logoPetMed Express, Inc. D/B/A 1-800-PETMEDS Announces Its Financial Results for Fiscal 2017 and Its Quarterly Dividend Raised to $0.20 Per Share - May 8 at 12:04 PM logoSomewhat Favorable Media Coverage Somewhat Likely to Affect Petmed Express (PETS) Stock Price - May 4 at 7:01 PM logoBruce S. Rosenbloom Sells 1,500 Shares of Petmed Express Inc (PETS) Stock - May 3 at 7:34 PM logoBlog Coverage Alkermes Announces Completion of Patient Enrolment in ALKS 3831 Study for the Treatment of Schizophrenia - May 2 at 10:41 AM logoPetmed Express (PETS) Getting Somewhat Critical Media Coverage, AlphaOne Reports - May 1 at 3:44 PM logoPetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 8, 2017 - May 1 at 11:42 AM logoPetmed Express (PETS) Given Daily Media Sentiment Rating of 0.29 - April 28 at 12:52 AM logo$56.3 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter - April 27 at 11:52 AM logoPetmed Express Inc (PETS) Expected to Announce Earnings of $0.26 Per Share - April 25 at 5:18 PM logoPetmed Express (PETS) Earns Daily News Impact Score of 0.50 - April 24 at 3:00 PM logoPetmed Express (PETS) Getting Favorable News Coverage, Analysis Shows - April 20 at 8:11 PM logoPetmed Express (PETS) Earning Favorable News Coverage, Study Finds - April 17 at 1:04 PM logoPetmed Express (PETS) Given Daily Media Impact Rating of 0.39 - April 14 at 11:29 PM logoPetmed Express Inc (PETS) Stock Rating Upgraded by Zacks Investment Research - April 12 at 12:44 PM logoPetMed Express, Inc. breached its 50 day moving average in a Bearish Manner : PETS-US : April 5, 2017 - April 7 at 11:51 AM logoBlog Coverage Valeant's Bausch + Lomb Receives FDA Clearance for Vision Enhancement System - April 7 at 11:51 AM logoPetmed Express Inc (PETS) Lowered to Sell at Zacks Investment Research - April 4 at 3:09 PM logoPetmed Express Inc (PETS) Rating Increased to Hold at Zacks Investment Research - April 3 at 12:59 PM logoPetmed Express Inc (PETS) Upgraded to Hold at Zacks Investment Research - March 28 at 1:49 PM logoPetMed Express: A Surprising Dividend Stock - Seeking Alpha - March 24 at 8:27 AM logoAmsterDog Rescue, Supported by PetMed Express, Inc., Rings the NASDAQ Opening Bell to Celebrate National Puppy ... - Benzinga - March 24 at 8:27 AM logoPetmed Express Inc (PETS) Lowered to "Sell" at Zacks Investment Research - March 20 at 1:43 PM logoQ2 2018 EPS Estimates for Petmed Express Inc (PETS) Lowered by Analyst - March 16 at 2:06 PM logoZacks Investment Research Upgrades Petmed Express Inc (PETS) to Hold - March 14 at 2:54 PM logoPETMED EXPRESS INC Files SEC form 8-K, Other Events - February 8 at 8:09 PM logoPETMED EXPRESS INC Financials - February 3 at 8:00 PM logoPETMED EXPRESS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - January 25 at 11:36 PM logoQ3 2016 Petmed Express Inc Earnings Release - 08:00 am ET - January 24 at 12:31 AM



Petmed Express (PETS) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by Staff